SARTORIUS AG-VORZUG (SRT3.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:SRT3 - DE0007165631
252 EUR
+3 (+1.2%)
Taking everything into account, SRT3 scores 3 out of 10 in our fundamental rating. SRT3 was compared to 20 industry peers in the Life Sciences Tools & Services industry. SRT3 has a bad profitability rating. Also its financial health evaluation is rather negative. SRT3 is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year SRT3 was profitable.
In the past year SRT3 had a positive cash flow from operations.
Each year in the past 5 years SRT3 has been profitable.
In the past 5 years SRT3 always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of 1.39%, SRT3 is doing worse than 80.00% of the companies in the same industry.
With a Return On Equity value of 5.01%, SRT3 is not doing good in the industry: 70.00% of the companies in the same industry are doing better.
SRT3 has a worse Return On Invested Capital (4.71%) than 75.00% of its industry peers.
The Average Return On Invested Capital over the past 3 years for SRT3 is in line with the industry average of 9.25%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.39% | ||
| ROE | 5.01% | ||
| ROIC | 4.71% |
ROA(3y)4.22%
ROA(5y)4.59%
ROE(3y)15.69%
ROE(5y)18.55%
ROIC(3y)8.34%
ROIC(5y)10.45%
1.3 Margins
With a Profit Margin value of 3.80%, SRT3 is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
SRT3's Profit Margin has declined in the last couple of years.
SRT3's Operating Margin of 14.06% is on the low side compared to the rest of the industry. SRT3 is outperformed by 70.00% of its industry peers.
In the last couple of years the Operating Margin of SRT3 has declined.
With a decent Gross Margin value of 46.48%, SRT3 is doing good in the industry, outperforming 75.00% of the companies in the same industry.
SRT3's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.06% | ||
| PM (TTM) | 3.8% | ||
| GM | 46.48% |
OM growth 3Y-21.14%
OM growth 5Y-7.77%
PM growth 3Y-35.47%
PM growth 5Y-21.95%
GM growth 3Y-5.43%
GM growth 5Y-2.63%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so SRT3 is still creating some value.
Compared to 1 year ago, SRT3 has more shares outstanding
The number of shares outstanding for SRT3 has been increased compared to 5 years ago.
SRT3 has a better debt/assets ratio than last year.
2.2 Solvency
SRT3 has an Altman-Z score of 2.48. This is not the best score and indicates that SRT3 is in the grey zone with still only limited risk for bankruptcy at the moment.
SRT3 has a Altman-Z score (2.48) which is comparable to the rest of the industry.
The Debt to FCF ratio of SRT3 is 8.92, which is on the high side as it means it would take SRT3, 8.92 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 8.92, SRT3 is not doing good in the industry: 70.00% of the companies in the same industry are doing better.
SRT3 has a Debt/Equity ratio of 1.28. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 1.28, SRT3 is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.28 | ||
| Debt/FCF | 8.92 | ||
| Altman-Z | 2.48 |
ROIC/WACC0.58
WACC8.09%
2.3 Liquidity
A Current Ratio of 0.95 indicates that SRT3 may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.95, SRT3 is doing worse than 85.00% of the companies in the same industry.
A Quick Ratio of 0.49 indicates that SRT3 may have some problems paying its short term obligations.
SRT3's Quick ratio of 0.49 is on the low side compared to the rest of the industry. SRT3 is outperformed by 90.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.95 | ||
| Quick Ratio | 0.49 |
3. Growth
3.1 Past
SRT3 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 59.34%, which is quite impressive.
Measured over the past years, SRT3 shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -11.87% on average per year.
SRT3 shows a small growth in Revenue. In the last year, the Revenue has grown by 5.82%.
The Revenue has been growing by 13.10% on average over the past years. This is quite good.
EPS 1Y (TTM)59.34%
EPS 3Y-36.07%
EPS 5Y-11.87%
EPS Q2Q%24.14%
Revenue 1Y (TTM)5.82%
Revenue growth 3Y-0.67%
Revenue growth 5Y13.1%
Sales Q2Q%6.25%
3.2 Future
Based on estimates for the next years, SRT3 will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.29% on average per year.
Based on estimates for the next years, SRT3 will show a quite strong growth in Revenue. The Revenue will grow by 8.99% on average per year.
EPS Next Y22.69%
EPS Next 2Y21.53%
EPS Next 3Y22.9%
EPS Next 5Y19.29%
Revenue Next Year5.43%
Revenue Next 2Y6.87%
Revenue Next 3Y8.82%
Revenue Next 5Y8.99%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 55.26, SRT3 can be considered very expensive at the moment.
SRT3's Price/Earnings ratio is rather expensive when compared to the industry. SRT3 is more expensive than 85.00% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.59. SRT3 is valued rather expensively when compared to this.
Based on the Price/Forward Earnings ratio of 41.64, the valuation of SRT3 can be described as expensive.
85.00% of the companies in the same industry are cheaper than SRT3, based on the Price/Forward Earnings ratio.
SRT3 is valuated expensively when we compare the Price/Forward Earnings ratio to 23.80, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 55.26 | ||
| Fwd PE | 41.64 |
4.2 Price Multiples
SRT3's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. SRT3 is more expensive than 65.00% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of SRT3 is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 39.43 | ||
| EV/EBITDA | 24.32 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SRT3 does not grow enough to justify the current Price/Earnings ratio.
SRT3's earnings are expected to grow with 22.90% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.44
PEG (5Y)N/A
EPS Next 2Y21.53%
EPS Next 3Y22.9%
5. Dividend
5.1 Amount
With a yearly dividend of 0.37%, SRT3 is not a good candidate for dividend investing.
SRT3's Dividend Yield is comparable with the industry average which is at 0.71.
With a Dividend Yield of 0.37, SRT3 pays less dividend than the S&P500 average, which is at 2.31.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.37% |
5.2 History
The dividend of SRT3 has a limited annual growth rate of 3.71%.
Dividend Growth(5Y)3.71%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
SRT3 pays out 37.92% of its income as dividend. This is a sustainable payout ratio.
SRT3's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP37.92%
EPS Next 2Y21.53%
EPS Next 3Y22.9%
FRA:SRT3 (12/10/2025, 5:36:15 PM)
252
+3 (+1.2%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners4.42%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap18.87B
Revenue(TTM)3.52B
Net Income(TTM)133.70M
Analysts80
Price Target347.12 (37.75%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.37% |
Yearly Dividend0.74
Dividend Growth(5Y)3.71%
DP37.92%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.85%
Min EPS beat(2)-10.52%
Max EPS beat(2)4.83%
EPS beat(4)1
Avg EPS beat(4)-3.47%
Min EPS beat(4)-10.52%
Max EPS beat(4)4.83%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.05%
Min Revenue beat(2)-0.73%
Max Revenue beat(2)0.83%
Revenue beat(4)3
Avg Revenue beat(4)1.91%
Min Revenue beat(4)-0.73%
Max Revenue beat(4)4.87%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5.07%
PT rev (3m)4.85%
EPS NQ rev (1m)0%
EPS NQ rev (3m)3.45%
EPS NY rev (1m)0%
EPS NY rev (3m)0.12%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.71%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.03%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 55.26 | ||
| Fwd PE | 41.64 | ||
| P/S | 5.36 | ||
| P/FCF | 39.43 | ||
| P/OCF | 21.58 | ||
| P/B | 7.07 | ||
| P/tB | N/A | ||
| EV/EBITDA | 24.32 |
EPS(TTM)4.56
EY1.81%
EPS(NY)6.05
Fwd EY2.4%
FCF(TTM)6.39
FCFY2.54%
OCF(TTM)11.68
OCFY4.63%
SpS46.97
BVpS35.63
TBVpS-35.24
PEG (NY)2.44
PEG (5Y)N/A
Graham Number60.46
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.39% | ||
| ROE | 5.01% | ||
| ROCE | 6.33% | ||
| ROIC | 4.71% | ||
| ROICexc | 4.98% | ||
| ROICexgc | 17.77% | ||
| OM | 14.06% | ||
| PM (TTM) | 3.8% | ||
| GM | 46.48% | ||
| FCFM | 13.61% |
ROA(3y)4.22%
ROA(5y)4.59%
ROE(3y)15.69%
ROE(5y)18.55%
ROIC(3y)8.34%
ROIC(5y)10.45%
ROICexc(3y)8.77%
ROICexc(5y)11.17%
ROICexgc(3y)24.37%
ROICexgc(5y)31.52%
ROCE(3y)11.22%
ROCE(5y)14.06%
ROICexgc growth 3Y-35.26%
ROICexgc growth 5Y-11.95%
ROICexc growth 3Y-38.49%
ROICexc growth 5Y-19.53%
OM growth 3Y-21.14%
OM growth 5Y-7.77%
PM growth 3Y-35.47%
PM growth 5Y-21.95%
GM growth 3Y-5.43%
GM growth 5Y-2.63%
F-Score7
Asset Turnover0.37
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.28 | ||
| Debt/FCF | 8.92 | ||
| Debt/EBITDA | 3.69 | ||
| Cap/Depr | 92.32% | ||
| Cap/Sales | 11.25% | ||
| Interest Coverage | 2.65 | ||
| Cash Conversion | 94.72% | ||
| Profit Quality | 357.97% | ||
| Current Ratio | 0.95 | ||
| Quick Ratio | 0.49 | ||
| Altman-Z | 2.48 |
F-Score7
WACC8.09%
ROIC/WACC0.58
Cap/Depr(3y)148.03%
Cap/Depr(5y)150.65%
Cap/Sales(3y)13.71%
Cap/Sales(5y)12.64%
Profit Quality(3y)282.77%
Profit Quality(5y)224.27%
High Growth Momentum
Growth
EPS 1Y (TTM)59.34%
EPS 3Y-36.07%
EPS 5Y-11.87%
EPS Q2Q%24.14%
EPS Next Y22.69%
EPS Next 2Y21.53%
EPS Next 3Y22.9%
EPS Next 5Y19.29%
Revenue 1Y (TTM)5.82%
Revenue growth 3Y-0.67%
Revenue growth 5Y13.1%
Sales Q2Q%6.25%
Revenue Next Year5.43%
Revenue Next 2Y6.87%
Revenue Next 3Y8.82%
Revenue Next 5Y8.99%
EBIT growth 1Y18.65%
EBIT growth 3Y-21.66%
EBIT growth 5Y4.31%
EBIT Next Year101.8%
EBIT Next 3Y38.51%
EBIT Next 5Y26.81%
FCF growth 1Y123.33%
FCF growth 3Y7.25%
FCF growth 5Y29.73%
OCF growth 1Y6.61%
OCF growth 3Y4.07%
OCF growth 5Y20.79%
SARTORIUS AG-VORZUG / SRT3.DE FAQ
What is the ChartMill fundamental rating of SARTORIUS AG-VORZUG (SRT3.DE) stock?
ChartMill assigns a fundamental rating of 3 / 10 to SRT3.DE.
What is the valuation status for SRT3 stock?
ChartMill assigns a valuation rating of 1 / 10 to SARTORIUS AG-VORZUG (SRT3.DE). This can be considered as Overvalued.
Can you provide the profitability details for SARTORIUS AG-VORZUG?
SARTORIUS AG-VORZUG (SRT3.DE) has a profitability rating of 3 / 10.
Can you provide the PE and PB ratios for SRT3 stock?
The Price/Earnings (PE) ratio for SARTORIUS AG-VORZUG (SRT3.DE) is 55.26 and the Price/Book (PB) ratio is 7.07.
What is the expected EPS growth for SARTORIUS AG-VORZUG (SRT3.DE) stock?
The Earnings per Share (EPS) of SARTORIUS AG-VORZUG (SRT3.DE) is expected to grow by 22.69% in the next year.